COL5A2 and urinary bladder cancer: COL5A2 was involved in osteosarcoma cell proliferation and invasion, provided new insights into cytostatic drug resistance of ovarian cancer, and represented early potential diagnostic biomarkers and therapeutic targets for bladder cancer [42–44].